Skip to main content
. 2022 Aug 25;2022:6157026. doi: 10.1155/2022/6157026

Table 2.

Results of contrast-enhanced ultrasound nodules.

ACR ti-RADS classification Benign Malignant Predicted malignancy rate Actual malignancy rate (%)
TR3 5 2 <20% 10
TR4 3 4 <30% 20
TR5 2 4 >10% 20